semaj83/ctmatch_classification huggingface dataset:
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 30.0-65.0,  Cervical Cancer Woman between 30 and 65 years of age Covered by a Regional Cancer Screening Coordination Centre for cervical cancer in 4 of the pilot departments for the implementation of this organised screening, and participating in the study eligible for cervical cancer screening Having not had a cervical smear test for at least three years Not having responded within 6 months to a letter inviting a cervical-uterine smear test Residing in a Block Grouped for Disadvantaged Statistical Information, quintiles 4 & 5 according to the European Deprivation Index classification Covered by health insurance or AME  Ineligible for screening (e.g. hysterectomy or history of cervical cancer) Pregnant woman beyond 6 months of age Under guardianship or trusteeship
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Pelvic Organ Prolapse Stage II-IV pelvic organ prolapse Bothersome bulge symptoms At least 725 MET-minutes/week on International Physical Activity Questionnaire Short Form English-speaking Undergoing treatment of prolapse Surgery occurring at least 7 days from date of randomization (to allow for collection of at least 7 days of preoperative accelerometer data) Able and willing to follow up at 3 months for in-office exam  Enrollment in another research study of pelvic organ prolapse Concomitant non-urogynecologic surgery Planned further surgery in the next 3 months or anticipated treatment which would result in prolonged inactivity (such as a cancer diagnosis) 3 months postoperatively
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-70.0,  Breast Neoplasm Malignant Female women between 18 and 70 years old patient with histologically confirmed breast cancer adjuvant situation spoken language : french patient who never had chemotherapy in the past  Patient unable to sit Malformation of the back Wound at the level of the zones to massage Patient placed under the authority of a tutor Pregnant patient
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 25.0-56.0,  Cervical Cancer HIV/AIDS Women living in Limbe town and neighborhood Confirmed to be HIV[+] or HIV[-] Have never undergone cervical cancer screening, with no history of ICC Willing and able to competently understand and provide written, informed paper-based consent Women who are having a menstrual period will be deferred for 2 weeks from participating in the study  Pregnant women Women with signs of abnormalities Non-menstrual bleeding suggestive of ICC Without a cervix because they have undergone hysterectomy Based on the judgment of the clinicians not sufficiently healthy to participate in a research study
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Sepsis Septic Shock Healthy Male or female, aged ≥ 18 years. 2. Apparently healthy as determined by a subject questionnaire  Current diagnosis, or history, of any underlying major medical condition determined by the investigator, including but not limited to: 1. Heart disease 2. Stroke 3. Renal disease 4. Liver disease 5. Pancreatic disease 6. Chronic obstructive pulmonary disorder 7. Bleeding disorders 8. Hypercalcitoninemia 9. HIV AIDS 10. Receiving antibiotic therapy 11. Suspected infection 12. Immunosuppression 2) Underwent procedures related to sepsis, or diagnosed with sepsis, within the last 12 months. 3) Current diagnosis of uncontrolled hypertension, hypotension, or diabetes. 4) Diagnosis of bacterial, fungal, or malaria infection within the last 3 months that required antimicrobial treatment. 5 )Experienced severe trauma, surgery, cardiac shock, or severe burn within the previous 3 months requiring medical care. 6) Current diagnosis of cancer within the last 12 months. 7) Received immunotherapy to stimulate or inhibit cytokines within the last 12 months. 8) Hospitalization for more than 24 hours within the last 3 months. 9) Reported as currently pregnant or nursing a child 10) Unable or unwilling to provide the required blood sample for testing. 11) Any other that, in the opinion of the investigator, would render the participant unsuitable for in the trial
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 30.0-64.0,  Cervical Carcinoma Human Papillomavirus Infection Not within recommended cervical cancer screening guidelines for women in this age range (i.e., no Papanicolaou [Pap] test in last 3 years or no Pap test plus clinic-based HPV test in last 5 years) Resident of an Appalachian county Not currently pregnant Intact cervix No history of invasive cervical cancer Seen in a participating clinic/health system in last 2 years (i.e., active patient) Have a working telephone
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 30.0-70.0,  Pain Biological female Aged 30-70 Provision of written informed consent  History of pelvic or vaginal surgery, active infectious gynecologic complaint, prior intervention for abnormal cervical cytology Incapable of understanding the numeric pain scale Incapable of communicating in Chinese, English, or Taiwanese Prior cervical cancer diagnosis Prior hysterectomy Pregnant women
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 30.0-69.0,  Human Papilloma Virus Cervical Cancer CIN 2/3 Female Age 30-69 Undergoing cervical cancer screening, diagnostic procedure (colposcopy), or treatment (LEEP)  Pregnancy History of Cervical Cancer Prior hysterectomy Inability to provide informed consent
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Breast Cancer Cervical Cancer women who identify as Hispanic/Latina ancestry or descent and live in the Greater Houston Area in Texas no previous diagnosis of breast or cervical cancer  Pregnant women, and women who are adherent to screening guidelines prior or current cancer diagnosis
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 13.0-30.0,  Obesity Malignant Neoplasm Patients with a history of HSCT of any type, at least 100 days post-transplant at initial consultation of the study, will be eligible for the study Patients must classify as obese, represented as body mass index (BMI) >= 85th percentile for age and gender Patients must also be able to read English since the app intervention is only available in English form No patients will be excluded for any specific underlying medical condition, but decisions will be made on a case by case basis if a patient's functioning is deemed to significantly interfere with intervention participation His/her child meets all >= 18 years of age Can speak English  Patients who are < 100 days post-transplant at initial consultation will not be eligible for the study, but may become eligible if they are > 100 days post-transplant at their next consultation that falls within the enrollment window Patients whose BMI does not fall under the obese category will be excluded
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 21.0-64.0,  Cervical Cancer Female subjects ≥ 21 of age and < 65 of age Subjects who have signed the inform consent form  Pregnant subjects Subjects who have had cervical cytology samples taken in the last 12 months Subjects who have previously undergone a total hysterectomy Subjects who have previously undergone cone resection, LEEP, cervical laser surgery, cervical cryosurgery or uterine ablation within 3 years Subjects who are participating in other clinical trials of cervical disease diagnostic products
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Single Embryo Pregnancy Gestational Weeks 24-42 Pain/Sensitivity >5 on Numeric Rating Scale (NRS) Women > 18 years Single embryo pregnancy in week 24-42 was diagnosed with symphysiolisis according to written above Pain/sensitivity >5 on NRS scale in symphysis pubis area for more than two weeks  Lack of proficiency in Hebrew or English Pain from a different source pelvic bone disease or history of severe pelvic bone injury Thrombocytopenia (plt<50.000) Acupuncture treatment is contraindicated High risk pregnancy
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Renal Tumor •CT-confirmed renal mass > 4 to 7 cm (T1b)  Multiple renal tumors Recurrence of renal tumor Intolerance to iodine-containing contrast agents Pregnancy Patients with Bosniak 4 cysts Presence of other oncological diseases Impossibility of organ-preserving treatment due to the proximity of the tumor to the vessels or the calyx-pelvic system Absence of malignant pathology based on prior biopsy
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-90.0,  Gynecologic Cancer Endometrial Cancer Cervical Cancer Quality of Life Opioid Use New diagnosis of either 1) endometrial cancer undergoing surgery or 2) cervical cancer undergoing chemo-sensitizing radiation Access to a smartphone  Non-English speaking No access to smartphone Current use of Headspace application
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 25.0-64.0,  Human Papillomavirus (HPV)-Related Cervical Cancer HPV DNA Signature of informed consent Women with an active sex life Women 25 to 64 years old Patients without hysterectomy, conization of the cervix Patients without radiotherapy treatment, cervical chemotherapy hours before taking the sample, they should not use douches, ovules, lubricants or gels  Patients who have not started a sexual life Patients with uterine surgery Patients pregnant Patients with vaginal bleeding Patients who have had sexual activity 24 hours prior to taking the sample
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-52.0,  Diabetes Mellitus, Type 1 Contraception Women aged 18-52 years (reproductive age) who are not currently pregnant Previous diagnosis of Diabetes Mellitus  Inability to understand and write in the English language Unable to participate due to other factors, as assessed by the Chief Investigators A history of gestational diabetes but not diabetes mellitus Pregnant women
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Sexually Transmitted Diseases Gonorrhea Chlamydia Subject Recruitment Subjects must meet both of the following 1. Urogenital CT and/or GC infection (documented in a retrievable medical record) within the 16 weeks prior to enrollment and one or more of the additional risk factors included below to 24 years of age at the screening visit New sex partner within the past 12 weeks (84 days) More than one current sex partner Knowledge that current sex partner has multiple partners Partner with known sexually transmitted infection (STI) Inconsistent condom use among persons who are not in a mutually monogamous relationship 2. After three unsuccessful documented attempts to obtain medical records, the subject has a self-reported history of infection less than 17 weeks prior to enrollment AND two or more of the following additional risk factors to 24 years of age at the screening visit New sex partner within the past 12 weeks (84 days)  In the opinion of the Investigator, has a history of substance or alcohol abuse in the last 12 months or, has issues, conditions, or concerns that may compromise the safety of the subject, impact the subject's compliance with the protocol requirements, or confound the reliability of the data acquired Women who have undergone a total hysterectomy (had uterus and cervix removed). However, women with subtotal hysterectomy with an intact cervix may be enrolled Has a history or expectation of noncompliance with medications or intervention protocol Has engaged in sexual vaginal intercourse or douching, or used of any form of vaginal suppository or intravaginal device (with the exception of contraceptive vaginal ring or tampons) for 24 hours prior to enrollment (may be enrolled at a later date if all other are met) Menstruating at enrollment (may be enrolled at a later date if all other are met) Is currently being treated, or has been treated, for a period of 21 days prior to enrollment, with any prohibited antibiotics. The prohibited antibiotics azithromycin, erythromycin, doxycycline, levofloxacin, ofloxacin, ceftriaxone, and cefixime In the opinion of the Investigator, has signs/symptoms that indicate persistence of CT or GC infection diagnosed at screening, new interval infection, and/or a failure to comply with or complete the prescribed treatment regimen following a positive screening NAAT
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  HIV-1-infection Gonorrhea Male Chlamydia Partner Communication Anatomically male at birth 2. Condomless anal intercourse with an HIV serodiscordant or unknown serostatus male or transgender female partner in the previous 6 months 3. 18 years of age or older 4. Diagnosis of Gonorrhea and/or Chlamydia infection at any anatomic site at the Screening visit  Inability to understand the study procedures or to provide informed consent
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Total Hip Arthroplasty • All adult patients with unilateral programmed total hip prosthesis surgery are included in the absence of criteria Obligation for all patients to be affiliated with social security Patient Informed Consent Signature  chronic opiod consumption pregnancy mental disorder that prevents the usage of the numeric analog scale Contra indications of the realization of QLB Local infection Allergic to the local anesthesia Hemostasis disorder Incapacity of giving the consent : individuals under guardianship by court order, or under judicial protection
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Chronic Pancreatitis Genetic Mutation Smoking, Tobacco Drinking, Alcohol patients with a diagnosis of chronic pancreatitis agree to join the study and provide informed consent  autoimmune pancreatitis pancreatic cancer diagnosed within 2 years after the diagnosis of chronic pancreatitis the follow-up time less than 3 years
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma, Not Otherwise Specified Infiltrating Cervical Carcinoma Metastatic Cervical Carcinoma Recurrent Cervical Carcinoma Stage I Cervical Cancer FIGO 2018 Stage IA Cervical Cancer FIGO 2018 Stage IA1 Cervical Cancer FIGO 2018 Stage IA2 Cervical Cancer FIGO 2018 Stage IB Cervical Cancer FIGO 2018 Stage IB1 Cervical Cancer AJCC v8 Stage IB2 Cervical Cancer FIGO 2018 Stage IB3 Cervical Cancer FIGO 2018 Stage II Cervical Cancer FIGO 2018 Stage IIA Cervical Cancer FIGO 2018 Stage IIA1 Cervical Cancer FIGO 2018 Stage IIA2 Cervical Cancer FIGO 2018 Stage IIB Cervical Cancer FIGO 2018 Stage III Cervical Cancer FIGO 2018 Stage IIIA Cervical Cancer FIGO 2018 Stage IIIB Cervical Cancer FIGO 2018 Stage IIIC Cervical Cancer FIGO 2018 Stage IIIC1 Cervical Cancer FIGO 2018 Stage IIIC2 Cervical Cancer FIGO 2018 Stage IV Cervical Cancer FIGO 2018 Stage IVA Cervical Cancer FIGO 2018 Stage IVB Cervical Cancer FIGO 2018 Able to provide written consent Patient has given permission to give tumor/blood sample for research testing Histological confirmation of squamous cell carcinoma or adenosquamous carcinoma Known HPV status defined as positive staining for p16 on immunohistochemistry (IHC) or DNA in situ hybridization (ISH) for HPV Willingness to return to enrolling institution for follow-up (during the Active Monitoring Phase of the study) Consent to allow blood specimens to be shared with potential external collaborators Cohort #1: Surgery alone for early stage disease (Federation of Gynecology and Obstetrics [FIGO] stage IA-IB1) FIGO 2019 stage IA1, IA2, IB1 Plan to undergo surgery including but not limited to trachelectomy, radical hysterectomy, and lymph node dissection Cohort #2: Post-operative radiation +/  Other active malignancy =< 2 years prior to registration Non-melanotic skin cancer NOTE: If there is a history or prior malignancy, they must not be receiving other specific treatment for cancer Pregnancy or lactation Inability on the part of the patient to understand the informed consent to be compliant with the protocol